‘I Think From the Beginning, the Ambitions Were Compromised’: A Case Study of COVAX as Vaccine Equity Policy Operationalisation
The International Journal of Health Planning and Management · 2026-01 · 41 (1) · 59-70
DOI: 10.1002/hpm.70028 ↗Kurz gefasst
Fachartikel in der Zeitschrift The International Journal of Health Planning and Management, online erschienen am 30.09.2025. Verfasst von Charnele Nunes und 3 weiteren Autor:innen. Beteiligte Einrichtung: London School of Hygiene and Tropical Medicine (LSHTM), Faculty of Public Health and Policy, London, UK. Hauptthemen laut MEDLINE: Health Policy, COVID-19 Vaccines, Health Equity, COVID-19. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
COVAX was designed to support the discovery, development, and distribution of COVID‐19 vaccines globally, at scale and pace. This article examines how COVAX promoted vaccine equity and what lessons can be learnt.
Methods
Informed by a scoping review of lessons learnt from GHPs, we reviewed 109 documents related to COVAX and other GHPs and conducted 23 key informant interviews with representatives from GHPs, civil society, academia, and the private sector. Data were synthesised thematically using Rushton and Williams's framework.
Results
Data showed how the global health policy context shaped COVAX, with experience with Gavi and CEPI influencing its governance structure. We highlighted weaknesses in transparency and accountability, limited engagement with civil society organisations [CSO] and LMIC stakeholders, contested policy debates (e.g., different framing) and paradigms (e.g., prioritising technical and financial over political solutions).
Conclusions
COVAX largely replicated existing GHP approaches, subsidising research and development and then paying for resulting discoveries. While recognising how this reflects global power structures, in the inevitable next global health crisis, the international health community must advocate for greater LMIC and CSO involvement in decision‐making, sharing of intellectual property and technology transfer, and rebalancing of flows of innovation costs and benefits to a broader range of actors across public and private sectors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- London School of Hygiene and Tropical Medicine (LSHTM), Faculty of Public Health and Policy, London, UK.
- School of Sociological Studies, Politics and International Relations, University of Sheffield, Sheffield, UK.
- Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore.
ORCID-Profile: Charnele Nunes, Martin Mckee, Simon Rushton, Natasha Howard
Zitieren
APA
Nunes, C., Mckee, M., Rushton, S., & Howard, N. (2026). ‘I Think From the Beginning, the Ambitions Were Compromised’: A Case Study of COVAX as Vaccine Equity Policy Operationalisation. The International Journal of Health Planning and Management, 41(1), 59-70. https://doi.org/10.1002/hpm.70028
Vancouver
Nunes C, Mckee M, Rushton S, Howard N. ‘I Think From the Beginning, the Ambitions Were Compromised’: A Case Study of COVAX as Vaccine Equity Policy Operationalisation. The International Journal of Health Planning and Management. 2026;41(1):59-70. doi:10.1002/hpm.70028
BibTeX
@article{Nunes2026,
author = {Nunes, Charnele and Mckee, Martin and Rushton, Simon and Howard, Natasha},
title = {‘I Think From the Beginning, the Ambitions Were Compromised’: A Case Study of COVAX as Vaccine Equity Policy Operationalisation},
journal = {The International Journal of Health Planning and Management},
year = {2026},
volume = {41},
number = {1},
pages = {59--70},
doi = {10.1002/hpm.70028}
}
EUVIMED